Prothrombin complex concentrate-related thrombotic risk following anticoagulation reversal

Thrombosis and Haemostasis

Volumn 107, Issue 3, 2012, Pages 599-

  Toth, Peter ^a   Makris, Mike ^a,b  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVITAMIN K; PROTHROMBIN COMPLEX;

ANTICOAGULATION; BLEEDING; FOLLOW UP; HUMAN; INTERNATIONAL NORMALIZED RATIO; LETTER; PRIORITY JOURNAL; RISK; THROMBOSIS;

BLOOD COAGULATION FACTORS; DISSEMINATED INTRAVASCULAR COAGULATION; HUMANS; THROMBOEMBOLISM;

EID: 84857730757     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH11-11-0773     Document Type: Letter

References (3)

1. Dentali F, Marchesi C, Pierfranceschi MG, et al. Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin k antagonists. A metaanalysis. Thromb Haemost 2011; 106: 429-438.
2. Preston FE, Laidlaw ST, Sampson B, et al. Rapid reversal of oral anticoagulation with warfarin by a prothrombin complex concentrate (Beriplex): efficacy and safety in 42 patients. Br J Haematol 2002; 116: 619-624.
3. Carvalho M, Carneiro J, Monteiro C, al. E. Prothrombin complex concentrate for reversal of oral anticoagulation therapy in urgent situations. Experience of a single centre. J Thromb Haemost 2007; 5 (Suppl 2): Abstract P-M-174.